Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.42 |
| ▸ | FEN1 | P39748 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | ABL1 | P00519 | 7/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | CCR6 | P51684 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17157467 | 0.90 | ALOX5AP (0.45) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17157304 | 0.88 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19ABL1CCR6 | |
| SCHEMBL17157395 | 0.87 | ALOX5AP (0.44) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17157518 | 0.86 | ALOX5AP (0.47) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17172333 | 0.83 | ALOX5AP (0.43) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17172375 | 0.83 | ALOX5AP (0.43) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17172305 | 0.82 | ALOX5AP (0.42) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17172323 | 0.82 | ALOX5AP (0.45) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17172331 | 0.82 | ALOX5AP (0.41) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL17157450 | 0.81 | FEN1 (0.47) | ALOX5APFEN1CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150291632-A1 | METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES | DOW AGROSCIENCES LLC | 2015-10-15 | — | — | US | disclosed |
| US-20150291632-A1 | METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES | DOW AGROSCIENCES LLC | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291632-A1 | METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES | GPX1, POR, MGAM | ALOX5AP 2442/4885FEN1 753/4885CYP3A4 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.